Skip to main content

. 1985 Apr;38(4):475–477. doi: 10.1136/jcp.38.4.475

Technical method. Fresh frozen cryosupernatant in place of fresh frozen plasma for broad spectrum coagulation factor replacement.

J A Napier, H Bass, R Pengilley

PMCID: PMC499183 PMID: 3921573

475

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Boughton B. J., Simpson A. Plasma fibronectin in acute leukaemia. Br J Haematol. 1982 Jul;51(3):487–491. doi: 10.1111/j.1365-2141.1982.tb02806.x. [DOI] [PubMed] [Google Scholar]
Counts R. B., Haisch C., Simon T. L., Maxwell N. G., Heimbach D. M., Carrico C. J. Hemostasis in massively transfused trauma patients. Ann Surg. 1979 Jul;190(1):91–99. doi: 10.1097/00000658-197907000-00020. [DOI] [PMC free article] [PubMed] [Google Scholar]
Das P. C., Smit Sibinga C. T. Replacement fluid in plasma exchange. Lancet. 1980 Sep 20;2(8195 Pt 1):644–644. doi: 10.1016/s0140-6736(80)90310-4. [DOI] [PubMed] [Google Scholar]
Doran J. E. A critical assessment of fibronectin's opsonic role for bacteria and microaggregates. Vox Sang. 1983;45(5):337–348. doi: 10.1111/j.1423-0410.1983.tb01925.x. [DOI] [PubMed] [Google Scholar]
Graybeal F. Q., Jr, Mooreside D. E., Langdell R. D. Clotting factor activity in cryoprecipitates and supernatant plasma prepared from blood collected into ACD, ACD-adenine, CPD, and CPD-adenine and from plasma collected by plasmapheresis. Transfusion. 1969 May-Jun;9(3):135–140. doi: 10.1111/j.1537-2995.1969.tb05531.x. [DOI] [PubMed] [Google Scholar]
Katz A. J., Morse E. E. Factor V activity in fresh frozen and cryoprecipitate-removed plasma. Vox Sang. 1972 Jan;22(1):39–44. doi: 10.1111/j.1423-0410.1972.tb03964.x. [DOI] [PubMed] [Google Scholar]
Monthony J. F., Wallace E. G., Allen D. M. A non-barbital buffer for immunoelectrophoresis and zone electrophoresis in agarose gels. Clin Chem. 1978 Oct;24(10):1825–1827. [PubMed] [Google Scholar]

ACTIONS

RESOURCES